ALK expression defines a distinct group of T/null lymphomas ('ALK lymphomas') with a wide morphological spectrum

American Journal of Pathology

Volumn 153, Issue 3, 1998, Pages 875-886

  Falini, Brunangelo ^a,j   Bigerna, Barbara ^a   Fizzotti, Marco ^a   Pulford, Karen ^b   Pileri, Stefano A ^c   Delsol, Georges ^d   Carbone, Antonino ^e   Paulli, Marco ^f   Magrini, Umberto ^f   Menestrina, Fabio ^g   Giardini, Roberte ^h   Pilotti, Silvana ^h   Mezzelani, Alessandra ^h   Ugolini, Barbara ^a   Billi, Monia ^a   Pucciarini, Alessandra ^a   Pacini, Roberta ^a   Pelicci, Pier Giuseppe ⁱ   Flenghi, Leonardo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d CHU PURPAN   (France)

^e Centro Oncologico Aviano   (Italy)

^f UNIVERSITY OF PAVIA   (Italy)

^g UNIVERSITY OF VERONA   (Italy)

^h NATIONAL CANCER INSTITUTE   (Italy)

ⁱ EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^j Istituto di Ematologia   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTRANSFERASE;

ANAPLASTIC CARCINOMA; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031689795     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65629-5     Document Type: Article

References (53)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of Hodgkin's disease associated Ki-1 antigen in reactive and neoplastic lymphoid tissues: evidence that Sternberg-Reed cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985, 66:848-858
2. Falini B, Pileri S, Pizzolo G, Durkop H, Flenghi L, Stirpe F, Martelli MF, Stein H: CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood 1995, 85:1-14
3. Kadin ME: Primary Ki-1 positive anaplastic large cell lymphoma: a distinct clinicopathologic entity. Ann Oncol 1994, 5:25-30
4. Zinzani PL, Bendandi M, Martelli M, Falini B, Sabattini E, Amadori S, Gherlinzoni F, Martelli MF, Mandelli F, Tura S, Pileri S: Anaplastic large cell lymphoma: clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 1996, 14:955-962
5. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret J-L, Kristoffersson U, Magaud J-P, Nezelof C, Tilly H, Vannier J-P, Hemet J, Warnke R: CD30-positive large cell lymphomas (Ki-1 lymphoma) are associated with a chromosomal translocation involving 5q35. Br J Haematol 1990, 74:161-168
6. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994, 263: 1281-1284
7. Ladany M: The NPM/ALK gene fusion in the pathogenesis of anaplastic large cell lymphoma. Cancer Surv 1997, 30:59-75
8. Fujimoto J, Shiota M, Iwahara T, Seki N, Satoh H, Mori S, Yamamoto T: Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci USA 1996, 93:4181-4186
9. Chan PK, Chan FY, Morris SW, Liu QR: Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: identification of the YY1 binding site at the 5′ enhancer region. Nucleic Acids Res 1996, 25:1225-1232
10. Morris SW, Naeve C, Mathew P, James PL, Kirstein MN, Cui X, Witte DP: ALK, the chromosome 2 gene locus altered by the t(2;5) in non-Hodgkin's lymphoma, encodes a novel neural tyrosine kinase that is highly related to leukocyte tyrosine kinase (LTK). Oncogene 1997, 14:2175-2188
11. Iwahara T, Fujimoto J, Wen D, Cupples R, Bucay N, Arakawa T, Mori S, Ratzkin B, Yamamoto T: Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 1997, 14:439-449
12. Bischof D, Pulford K, Mason DY, Morris SW: Role of nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic kinase fusion protein in oncogenesis. Mol Cell Biol 1997, 17:2312-2325
13. Kuefer MU, Look AT, Pulford K, Behm FG, Pattengale PK, Mason DY, Morris SW: Retrovirus-mediated gene transfer of NPM-ALK causes lymphoid malignancy in mice. Blood 1997, 90:2901-2910
14. Downing J, Shurtleff S, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT, Weinburger D, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris S: Molecular detection of the t(2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 1995, 85:3416-3422
15. Shiota M, Fujimoto J, Takenaga M, Satoh H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994, 84: 3648-3652
16. NPM/ALK: a distinct clinicopathologic entity. Blood 1995, 86:1954-1960
17. Hutchinson RE, Banki K, Shuster JJ, Barrett D, Dieck C, Berard CW, Murphy SB, Link MP, Pick TE, Laver J, Schwenn M, Mathew P, Morris SW: Use of an anti-ALK antibody in the characterization of anaplastic large-cell lymphoma of childhood. Ann Oncol 1997, 8:37-42
18. Pulford K, Lamant L, Morris S, Butler LH, Wood KM, Stroud D, Delsol G, Mason DY: Detection of ALK and NPM-ALK protein in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997, 89:1394-1404
19. Herbst H, Anagnostopoulos J, Heinze B, Durkop H, Hummel M, Stein H: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 1995, 86:1694-1700
20. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC: Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma. Hodgkin's disease, and reactive lymphoid lesions. Blood 1995, 86:3517-3521
21. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M: Analysis of the t(2;5)(p23:q35) translocation by reverse transcription polymerase chain reaction in CD30+ anaplastic large cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 1995, 86:2321-2328
22. Lopategui JR, Sun LH, Chan JK, Gaffey MJ, Frierson HF Jr, Glackin C, Weiss LM: Low frequency association of the t(2;5)(p23;q35) chromosomal translocation with CD30+ lymphomas from American and Asian patients: a reverse transcriptase-polymerase chain reaction study. Am J Pathol 1995, 146:323-328
23. Weisenburger DD, Gordon BG, Vose JM, Bast MA, Chan WC, Greiner TC, Anderson JR, Sanger WG: Occurrence of the t(2;5)(p23;q35) in non-Hodgkin's lymphoma. Blood 1996, 87:3860-3868
24. Lamant L, Meggetto F, Al Saati T, Bruggieres L, Bressac de Paillerets B, Dastague N, Bernheim A, Ruble H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Delsol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and P-80 immunostaming. Blood 1996, 87:284-291
25. Sarris AH, Rajyalakshmi L, Papadimitracopoulou V, Waasdorp M, Dimopoulos M, McBride JA, Cabanillas F, Duvic M, Deisseroth A, Morris S, Pugh WC: Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not in other non-Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis. Blood 1996, 88:1771-1779
26. DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME: The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996, 87:3437-3441
27. Shiota M, Mori S: Anaplastic large cell lymphomas expressing the novel chimeric protein p80NPM/ALK: a distinct clinicopathologic entity. Leukemia 1997, 11:538-540
28. Nakamura S, Shiota M, Nakagawa A, Yatabe Y, Kojima M, Motoori T, Suzuki R, Kagami Y, Ogura M, Morishima Y, Mizoguchi Y, Okamoto M, Seto M, Koshikawa T, Mori S, Suchi T: Anaplastic large cell lymphoma: a distinct molecular pathologic entity: a reappraisal with special reference to p80 (NPM/ALK) expression. Am J Surg Pathol 1997, 21:1420-1432
29. Stein H: Ki-1 anaplastic large cell lymphoma: is it a discrete entity? Leuk Lymphoma 1993, 10:81-84
30. Chan JKC, Ng CS, Hui PK, Leungs TW, Lau WH, McGuire LJ: Anaplastic large cell Ki-1 lymphoma: delineation of two morphological types. Histopathology 1989, 15:11-34
31. Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, Martelli MF, Rivano MT, Mason DY, Stansfeld AG: Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/Ki-1+ with a high content of reactive histiocytes). Histopathology 1990, 16:383-39
32. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME: A small cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 1993, 17:859-868
33. Mann KP, Hall B, Kamino J, Borowitz MJ, Ratech H: Neutrophil-rich, Ki-1-positive anaplastic large cell malignant lymphoma. Am J Surg Pathol 1995, 19:407-416
34. Chan JKC, Buchanan R, Fletcher CDM: Sarcomatoid variant of anaplastic large-cell lymphoma. Am J Surg Pathol 1990, 14:983-988
35. Falini B, Liso A, Pasqualucci L, Flenghi L, Ascani S, Pileri S, Bucciarelli E: CD30+ anaplastic large cell lymphoma, null type, with signet-ring appearance. Histopathology 1997, 30:90-92
36. Kadin ME: Anaplastic large cell lymphoma and its morphological variants. Cancer Surv 1997, 30:77-86
37. Flenghi L, Bigerna B, Fizzotti M, Venturi S, Pasqualucci L, Pileri S, Ye BH, Gambacorta M, Pacini R, Baroni C, Pescarmona E, Anagnostopoulos I, Stein H, Asdrubali G, Martelli MF, Pelicci PG, Dalla Favera R, Falini B: Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol 1996, 148: 1543-1555
38. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY: Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229
39. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FG, Karpas A: A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2;5 translocation and rearrangement of the T-cell receptor β-chain gene. Blood 1988, 72:234-240
40. Pear WS, Nolan GP, Scott ML, Baltimore D: Production of high-titer helper-free retrovirus by transient transfection. Mol Cell Biol 1993, 90:8392-8396
41. Cattoretti G, Suurmeijer AJH: Antigen unmasking on formalin-fixed paraffin-embedded tissues using microwaves: a review. Adv Anat Pathol 1995, 2:2-9
42. Pileri S, Roncador G, Ceccarelli C, Piccioli M, Briskomatis A, Sabattini E, Ascani S, Santini D, Piccaluga PP, Leone O, Damiani S, Ercolessi C, Sandri F, Pieri F, Leoncini L, Falini B: Antigen retrieval techniques in immunohistochemistry: comparison of different methods. J Pathol 1997, 183:116-123
43. Harris NL, Jaffe ES, Stein H, Banks P, Chan JKC, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Ralfkier E, Warnke RA: A Revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994, 84:1361-1392
44. Bennet JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia: a report of the French-American-British Cooperative Group. Ann Int Med 1985, 103:620-625
45. Ponder BA, Wilkinson WN: Inhibition of endogenous tissue alkaline phosphatase with the use of alkaline phosphatase conjugates in immunohistochemistry. J Histochem Cytochem 1981, 29:981-986
46. Gambacorta M, Flenghi L, Fagioli M, Pileri S, Leoncin, L, Bigerna B, Pacini R, Natali Tanci L, Pasqualucci L, Ascani S, Mencarelli A, Liso A, Pelicci PG, Falini B: Heterogeneous nuclear expression of the promyelocytic (PML) protein in normal and neoplastic human tissues. Am J Pathol 1996, 149:2023-2035
47. Pittaluga S, Wiodarska I, Pulford K, Campo E, Morris SW, Van den Berghe H, De Wolf-Peeters C: The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 1997, 151:343-351
48. Delsol G, Lamant L, Mariamé B, Pulford K, Dastugue N, Brousset P, Rigal-Huguet F, Al Saati T, Cerretti DP, Morris SW, Mason DY: A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2;5 translocation. Blood 1997, 89:1483-1490
49. Li G, Salhany KE, Rook AH, Lessin SR: The pathogenesis of large cell transformation in cutaneous T-cell lymphoma is not associated with t(2;5)(p23;q35) chromosomal translocation. J Cutan Pathol 1997, 24: 403-408
50. Benharroch D, Meguerian-Bedoyan Z, Lamant L, Amin C, Brugieres L, Terrier-Lacombe MJ, Haralambieva E, Pulford K, Pileri S, Morris S, Mason DY, Delsol G: ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998, 91:2076-2084
51. Pileri SA, Mason DY, Mori S, Pulford K, Sabattini E, Roncador G, Piccaluga PP, Stein H, Falini B: Frequent expression of the p80 NPM-ALK chimeric fusion protein in anaplastic large cell lymphoma, lympho-histiocytic type. Am J Pathol 1997, 150:1207-1211
52. Mason DY, Pulford K, Bischof D, Kuefer MU, Butler LH, Lamant L, Delsol G, Morris S: Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase tyrosine kinase is not required for malignant transformation. Cancer Res 1998, 58:1057-1062
53. Pileri S, Sabattini E, Falini B: Lymphohistiocytic T-cell lymphoma and peripheral T-cell lymphoma associated with haemophagocytic syndrome: two recently recognized entities which mimic malignant histiocytosis. Leuk Lymphoma 1992, 6:317-324